Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years

被引:11
作者
Moller, Burkhard [1 ]
Aletaha, Daniel [2 ]
Andor, Michael [3 ]
Atkinson, Andrew [1 ,4 ]
Aubry-Rozier, Berengere [5 ]
Brulhart, Laure [6 ]
Dan, Diana [5 ]
Finckh, Axel [7 ]
Grobety, Veronique [8 ]
Mandl, Peter [2 ]
Micheroli, Raphael [9 ]
Nissen, Michael John [7 ]
Nydegger, Alexander M. [10 ]
Scherer, Almut [4 ]
Tamborrini, Giorgio [11 ]
Ziswiler, Hans-Rudolf [12 ]
Zufferey, Pascal [5 ]
机构
[1] Univ Hosp Bern, Inselspital, Rheumatol Immunol & Allergy, Bern, Switzerland
[2] Med Univ Vienna, Med Dept 3, Rheumatol, Vienna, Austria
[3] Prodorso, Zurich, Switzerland
[4] SCQM Stat Grp, Zurich, Switzerland
[5] Lausanne Univ Hosp, Rheumatol, Lausanne, Switzerland
[6] Hop Neuchatelois, Rheumatol, La Chaux De Fonds, Switzerland
[7] Univ Hosp Geneva, Rheumatol, Geneva, Switzerland
[8] Victoriapl Ctr Rheumatol, Bern, Switzerland
[9] Univ Hosp Zurich, Rheumatol, Zurich, Switzerland
[10] Klin Schloss Mammern, Rheumatol & Rehabil, Mammern, Switzerland
[11] Basel Inst Locomotor Syst Ultrasound, Basel, Switzerland
[12] Osteorheuma, Bern, Switzerland
关键词
rheumatoid arthritis; hand; synovium; ultrasonography; biological therapies; MODIFYING ANTIRHEUMATIC DRUGS; CLINICAL-DISEASE ACTIVITY; AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; RADIOGRAPHIC PROGRESSION; PLUS METHOTREXATE; PROVISIONAL DEFINITION; JOINT DAMAGE; REMISSION; RECOMMENDATIONS;
D O I
10.1093/rheumatology/kez460
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To evaluate grey scale US (GSUS) and power Doppler US synovitis (PDUS), separately or in combination (CombUS), to predict joint damage progression in RA. Methods. In this cohort study nested in the Swiss RA register, all patients with sequential hand radiographs at their first US assessment were included. We analysed the summations of semi-quantitative GSUS, PDUS and CombUS assessments of both wrists and 16 finger joints (maximum 54 points) at their upper limit of normal, their 50th, 75th or 87.5th percentiles for the progression of joint damage (Delta Xray). We adjusted for clinical disease activity measures at baseline, the use of biological DMARDs and other confounders. Results. After a median of 35 months, 69 of 250 patients with CombUS (28%), 73 of 259 patients with PDUS (28%) and 75 of 287 patients with available GSUS data (26%) demonstrated joint damage progression. PDUS beyond upper limit of normal (1/54), GSUS and CombUS each at their 50th (9/54 and 10/54) and their 75th percentiles (14/54 and 15/54) were significantly associated with Delta Xray in crude and adjusted models. In subgroup analyses, GSUS beyond 14/54 and CombUS higher than 15/54 remained significantly associated with Delta Xray in patients on biological DMARDs, while clinical disease activity measures had no significant prognostic power in this subgroup. Conclusion. Higher levels of GSUS and CombUS are associated with the development of erosions. GSUS appears to be an essential component of synovitis assessment and an independent predictor of joint damage progression in patients on biological DMARDs.
引用
收藏
页码:1556 / 1565
页数:10
相关论文
共 47 条
  • [1] The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care
    Aletaha, Daniel
    Smolen, Josef S.
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2007, 21 (04): : 663 - 675
  • [2] Achieving Clinical Remission for Patients With Rheumatoid Arthritis
    Aletaha, Daniel
    Smolen, Josef S.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (05): : 457 - 458
  • [3] Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity
    Aletaha, Daniel
    Alasti, Farideh
    Smolen, Josef S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (06) : 875 - 880
  • [5] 2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
    Aletaha, Daniel
    Neogi, Tuhina
    Silman, Alan J.
    Funovits, Julia
    Felson, David T.
    Bingham, Clifton O., III
    Birnbaum, Neal S.
    Burmester, Gerd R.
    Bykerk, Vivian P.
    Cohen, Marc D.
    Combe, Bernard
    Costenbader, Karen H.
    Dougados, Maxime
    Emery, Paul
    Ferraccioli, Gianfranco
    Hazes, Johanna M. W.
    Hobbs, Kathryn
    Huizinga, Tom W. J.
    Kavanaugh, Arthur
    Kay, Jonathan
    Kvien, Tore K.
    Laing, Timothy
    Mease, Philip
    Menard, Henri A.
    Moreland, Larry W.
    Naden, Raymond L.
    Pincus, Theodore
    Smolen, Josef S.
    Stanislawska-Biernat, Ewa
    Symmons, Deborah
    Tak, Paul P.
    Upchurch, Katherine S.
    Vencovsky, Jiri
    Wolfe, Frederick
    Hawker, Gillian
    [J]. ARTHRITIS AND RHEUMATISM, 2010, 62 (09): : 2569 - 2581
  • [6] [Anonymous], 2016, BMJ
  • [7] Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset
    Berglin, E
    Johansson, T
    Sundin, U
    Jidell, E
    Wadell, G
    Hallmans, G
    Rantapää-Dahlqvist, S
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (04) : 453 - 458
  • [8] An Explanation for the Apparent Dissociation Between Clinical Remission and Continued Structural Deterioration in Rheumatoid Arthritis
    Brown, A. K.
    Conaghan, P. G.
    Karim, Z.
    Quinn, M. A.
    Ikeda, K.
    Peterfy, C. G.
    Hensor, E.
    Wakefield, R. J.
    O'Connor, P. J.
    Emery, P.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (10): : 2958 - 2967
  • [9] Brulhart L, 2015, CLIN EXP RHEUMATOL, V33, P98
  • [10] D'Agostino MA, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2016-000428